|
KMID : 1141520230380060597
|
|
Endocrinology and Metabolism
2023 Volume.38 No. 6 p.597 ~ p.618
|
|
|
2023 Korean Endocrine Society Consensus Guidelines for the Diagnosis and Management of Primary Aldosteronism
|
|
Ha Jeong-Hoon
Park Jung-Hwan
Kim Kyoung-Jin
Kim Jung-Hee
Jung Kyong-Yeun
Lee Jeong-Min
Choi Jong-Han
Lee Seung-Hun
Hong Nam-Ki
Lim Jung-Soo
Park Byung-Kwan
Kim Jung-Han
Jung Kyeong-Cheon
Cho Joo-Young
Kim Mi-kyung
Chung Choon-Hee
|
|
|
Abstract
|
|
|
|
Primary aldosteronism (PA) is a common, yet underdiagnosed cause of secondary hypertension. It is characterized by an overproduction of aldosterone, leading to hypertension and/or hypokalemia. Despite affecting between 5.9% and 34% of patients with hypertension, PA is frequently missed due to a lack of clinical awareness and systematic screening, which can result in significant cardiovascular complications. To address this, medical societies have developed clinical practice guidelines to improve the managementof hypertension and PA. The Korean Endocrine Society, drawing on a wealth of research, has formulated new guidelines for PA. Atask force has been established to prepare PA guidelines, which encompass epidemiology, pathophysiology, clinical presentation, diagnosis, treatment, and follow-up care. The Korean clinical guidelines for PA aim to deliver an evidence-based protocol for PA diagnosis, treatment, and patient monitoring. These guidelines are anticipated to ease the burden of this potentially curable condition.
|
|
|
KEYWORD
|
|
|
Primary aldosteronism, Hypertension, Diagnosis, Treatment, Guideline
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|
|